Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
1041.2000 0.35 (0.03%)
NSE May 21, 2026 09:29 AM
Volume: 227.0K
High vol.+gain this week

logo
Zydus Lifesciences Ltd.
21 Nov 2019
1041.20
0.03%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading above all available SMAs
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Market opens higher, Apollo Hospitals to sell kids & fertility biz valued at Rs 1,550 crore
Trendlyne Marketwatch | 21 May 2026, 09:21AM
Everyone's talking about the FII exodus, but there are stocks that they are buying
The Baseline | 20 May 2026, 06:54PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020